Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences, Inc. - Common Stock (NQ:NVOS)

0.1490 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Novo Integrated Sciences, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Appoints New President
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Announces Reverse Stock Split
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences’ Board of Directors Approves $5 Million Stock Repurchase Program
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Provides Update on Certain Current Events
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Signs Master Collateral Transfer Agreement
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health
From Novo Integrated Sciences, Inc.
Via Business Wire
News headline image
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program
From Novo Integrated Sciences, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.